<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08032595871453</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridine ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.154Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871460</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Repadina ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>1013</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.144Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871477</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina vagitoriji</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2009</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.136Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871484</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Repadina ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>2012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.127Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871491</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Vulniphan Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1045</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.117Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871507</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Vulniphan Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2029</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.106Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871514</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina vaginální čípky</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2024</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.086Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871699</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina Globulki dopochwowe</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.835Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871712</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>OFICINAL GIN PLUS óvulos vaginais</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.794Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871729</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>OFICINAL GIN PLUS óvulos vaginais</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.775Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871804</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CICATRIDINA PLUS вагинални овули</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1055</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.637Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871811</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CICATRIDINA PLUS вагинални овули</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2040</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871880</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina óvulos vaginales</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2048</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871927</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina κολπικά υπόθετα</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1071</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.413Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871934</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina κολπικά υπόθετα</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2050</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871965</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cikatridina Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2051</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871972</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cikatridina Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1072</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.364Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872054</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>Cicatridine PLUS ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1078</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.314Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872368</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CIKATRIDINE PLUS hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1094</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.214Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872375</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CIKATRIDINE PLUS hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2064</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.194Z</lastUpdated>
  </row>
</eudamedExport>